Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Resource Type
Article
Authors
Sridhar, Saranya ; Joaquin, Arnel ; Bonaparte, Matthew I ; Bueso, Agustin ; Chabanon, Anne-Laure ; Chen, Aiying ; Chicz, Roman M ; Diemert, David ; Essink, Brandon J ; Fu, Bo ; Grunenberg, Nicole A ; Janosczyk, Helene ; Keefer, Michael C ; Rivera M, Doris M ; Meng, Ya ; Michael, Nelson L ; Munsiff, Sonal S ; Ogbuagu, Onyema ; Raabe, Vanessa N ; Severance, Randall ; Rivas, Enrique ; Romanyak, Natalya ; Rouphael, Nadine G ; Schuerman, Lode ; Sher, Lawrence D ; Walsh, Stephen R ; White, Judith ; von Barbier, Dalia ; de Bruyn, Guy ; Canter, Richard ; Grillet, Marie-Helene ; Keshtkar-Jahromi, Maryam ; Koutsoukos, Marguerite ; Lopez, Denise ; Masotti, Roger ; Mendoza, Sandra ; Moreau, Catherine ; Ceregido, Maria Angeles ; Ramirez, Shelly ; Said, Ansoyta ; Tavares-Da-Silva, Fernanda ; Shi, Jiayuan ; Tong, Tina ; Treanor, John ; Diazgranados, Carlos A ; Savarino, Stephen
Source
In The Lancet Infectious Diseases May 2022 22(5):636-648
Subject
Primary Research Articles
Language
ISSN
1473-3099